Leaning back and wait for developments while digesting failures of competitors in the industry @Surges
It could be a case of severe indigestion for pharma and biotech in gene therapy. Interesting scenario that you have outlined. The rings of morpholino may yet rule precision medicine. We suspect that Dr Rosenblatt perfectly understands the science and the opportunity. There are indeed, 'Things I Wish I Knew' @SoT about how this would play out but isn't that the way in any investment. Better to build your position and wait for developments. The wait has been long but the force is strong with this one. I'm pretty sure I am mixing my metaphors.
Leaning back and wait for developments while digesting failures...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |